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Single-nucleotide polymorphisms inHORMAD1may be a
risk factor for azoospermia caused by meiotic arrest in
Japanese patients
Toshinobu Miyamoto1, Akira Tsujimura2, Yasushi Miyagawa2, Eitetsu Koh3, Mikio Namiki3,
Michiharu Horikawa1, Yasuaki Saijo4 and Kazuo Sengoku1
Genetic mechanisms are implicated as a cause of somemale infertility, yet are poorly understood. Meiosis is unique to germ cells and
essential for reproduction. The synaptonemal complex is a critical component for chromosome pairing, segregation and recombination.
Hormad1 is essential for mammalian gametogenesis as knockout male mice are infertile. Hormad1-deficient testes exhibit meiotic
arrest in the early pachytene stage and synaptonemal complexes cannot be visualized. To analyze the hypothesis that the human
HORMAD1 gene defects are associated with human azoospermia caused by meiotic arrest, mutational analysis was performed in all
coding regions by direct sequence analysis of 30 Japanese men diagnosed with azoospermia resulting from meiotic arrest. By the
sequence analysis, three polymorphism sites, Single Nucleotide Polymorphism 1 (c. 163A.G), SNP2 (c. 501T.G) and SNP3 (c.
918C.T), were found in exons 3, 8 and 10. The 30 patients with azoospermia and 80 normal pregnancy-proven, fertile men were
analyzed for HORMAD1 polymorphisms. Both SNP1 and SNP2 were associated with human azoospermia caused by complete early
meiotic arrest (P,0.05). We suggest that the HORMAD1 has an essential meiotic function in human spermatogenesis.
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INTRODUCTION
One of the most serious social problems facing Japan today is the
declining birth rate. However, it is generally not well recognized that
the number of infertile couples is on the rise in Japan. Although
social and environmental factors—such as social progress for
women and the resulting increase in the age at which women marry,
pollution and global warming—are behind part of the increase in
the number of patients with infertility, approximately half of all
cases of infertility are generally caused by factors related to the
man. To date, a variety of treatments have been developed for male
infertility, and these are steadily producing results. At present, how-
ever, there is no effective treatment for patients with non-obstruct-
ive azoospermia, in which there is an absence of mature sperm in the
testes. Although evidence suggests that many patients with azoos-
permia have a genetic predisposition to the condition, the cause has
not been elucidated in the vast majority of cases.1 The most frequent
genetic cause of azoospermia is represented by Klinefelter syn-
drome,2 and many cases of meiotic arrest (MA) are caused by the
presence of balanced chromosomal translocations.3 More genetic
causes of azoospermia in humans include Y-chromosome micro-
deletions and mutations in specific genes, including SYCP3, PRM1,
SPATA16, AURKC and KLHL10.4–8 As Y-chromosome deletions
account for only 9.4% of the cases of male infertility,9 azoospermia
may be caused by autosomal gene mutations. Genetic polymorph-
isms also increase susceptibility to some forms of male infertility,
e.g., the human SPATA17, PARP-2 and UBR2 genes are linked to
male infertility.10–12 Meiosis is a fundamental process in sexually
reproducing species that allows genetic exchange between maternal
and paternal genomes.13 Genetic regulation of meiosis in mammals
is poorly understood when compared to that in lower eukaryotes
such as yeast.
Proteins that contain a HORMA (Hop1, Rev7 and Mad2)-domain
regulate interactions between homologous chromosomes duringmei-
osis in a wide range of eukaryotes. Biochemical and cytological obser-
vations demonstrate that a mouse HORMA domain-containing
protein, HORMAD1, is associated with the meiotic chromosome
axis.14 Hormad1 is essential for mammalian gametogenesis as knock-
out male and female mice are infertile.15 Hormad1-deficient
(Hormad12/2) male germ cells arrest in the early pachytene stage,
and synaptonemal complexes are not evident in electron micrographs
of Hormad1-deficient male germ cells. HORMAD1 is a critical
component of the synaptonemal complex, which affects synapsis,
recombination and meiotic sex chromosome inactivation and tran-
scriptional silencing.15
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Here, we analyzed possible associations betweenHORMAD1muta-
tions and azoospermia caused by MA in humans.
MATERIALS AND METHODS
Study participants
Japanese patients with azoospermia caused by MA (n530) were
included in the study, and 80 healthy, pregnancy-proven, Japanese
fertilemenwere examined as controls. All normal controls had normal
sperm inspections, in addition to all having a child by spontaneous
pregnancy. All subjects were Japanese and provided written informed
consent for molecular blood analysis. This study was approved by the
local ethics committee.
Azoospermia in each patient was confirmed by two consecutive
semen analyses obtained after 5–7 days of sexual abstinence and by
examination of a centrifuged semen pellet. Patients with defective
spermatogenesis following infection, or due to obstruction of the
seminal tract, pituitary failure or other causes of possible testicular
damage revealed at clinical examinationwere excluded from the study.
Final diagnosis of azoospermia was carried out by histological exam-
ination. Samples from each patient were subjected to more than one
pathologic test. All patients included in the study had a normal 46: XY
karyotype based on chromosome analysis of peripheral lymphocytes.
There were no patients with Klinefelter syndrome and no patients with
balanced chromosome translocations. In addition, no patients had
Y-chromosome microdeletions.
Mutation screening
We screened 30 Japanese patients with azoospermia secondary to MA
for mutations in the HORMAD1 gene. Full-length cDNA sequences
(NM_032132) were compared to human genomic sequences
(NW_923184.1) by BLAST, and all exon/intron borders were deter-
mined. The following HORMAD1 primers were used for mutational
analysis: Exon 2: E2F1 and E2R1; Exons 3: E3F1 and E3R1; Exon 4:
E4F1 and E4R1; Exon 5: E5F1 and E5R1; Exon 6 and Exon 7: E6F1 and
E6R1; Exon 8: E8F1 andE8R1; Exon 9: E9F1 and E9R1; Exon 10: E10F1
and E10R1; Exon 11 and Exon 12: E11F1 and E11R1; Exon 13: E13F1
and E13R1; Exons 14: E14F1 and E14R1; and Exon 15: E15F1 and
E15R1. Sequences of oligonucleotide primers are listed in Table 1.
PCR was performed using primers for each intron region (Table 1):
with a final volume of 25 ml, consisting of genomic DNA (50 ng),
dNTPs (0.32 mmol l21 each), two primers (0.2 mmol l21 each),
0.2 mmol l21 Taq polymerase (0.625 IU) and reaction buffer contain-
ing MgCl2 as follows: initial denaturation at 95 uC for 150 s, followed
by 32 cycles of denaturation at 95 uC for 30 s, annealing at (primers Tm
25 uC) for 90 s and extension at 72 uC for 90 s. PCR products were
purified using a QIAquick PCR Purification kit (Qiagen, Tokyo,
Japan), and each product was sequenced directly. To confirm the role
of the detected polymorphisms in azoospermia, the coding region
of the HORMAD1 gene of 80 healthy, fertile control men was also
analyzed by direct sequencing and subsequent sequence analysis.
Sequence analysis was carried out on the patients with polymorphisms
four times and two times on normal controls; the patients and controls
were sequenced simultaneously.
Genotyping and statistical analyses
Single-locus analysis. To investigate the role of HORMAD1 poly-
morphisms in azoospermia, Fisher’s exact test was used to identify
meaningful differences. Hardy–Weinberg equilibrium was tested
using SNPAlyze software (Windows 2000/XP/Vista/7, 32-bit version;
Dynacom, Chiba, Japan). Linkage disequilibrium of all possible two-
way combinations of single-nucleotide polymorphisms (SNPs) with
the absolute value of the correlation coefficient (D9) were tested. P
values were determined by x2 approximation. Haplotype frequencies
were estimated by the maximum likelihood method based on the
expectation–maximization (E–M) algorithm under the assumption
of Hardy–Weinberg equilibrium. Linkage disequilibrium and haplo-
type frequencies were tested using SNPAlyze software. P values were
determined by x2 approximation; P,0.05 was considered to be sta-
tistically significant.
RESULTS
Mutation analysis of the HORMAD1 gene in the 30 patients revealed
three nucleotide changes: c. 163A.G in exon 3, c. 501T.G (Met 128
Arg) in exon 8, and c. 918C.T in exon 10. These changes, or SNPs,
were based on comparisons with the sequences published in the NCBI
dbSNP database. Only SNP3, c. 918C.T in exon 10, had been reported
previously; the others were newly identified SNPs (Table 2). Among
the three coding SNPs (cSNPs)—SNP1, 2 and 3, only SNP2 was non-
synonymous. The non-synonymous cSNP, SNP2, was tested using two
software tools, SIFT (free web site by University of British Columbia,
Canada) and PolyPhen (free web site by Harvard Medical School,
USA). The SIFT score of the Met128Arg change was 0.96 (.0.50),
and the Met128Arg was designated ‘benign’ based on the PolyPhen
analysis. Genotyping for the HORMAD1 SNP alleles among the 30
patients and 80 controls revealed significantly different genotype dis-
tribution and allele frequencies of SNP1 and SNP2 between the two
groups (P,0.005) (Table 2).
At the c. 163A.G site (SNP1), the proportion of GA heterozygote/
AA homozygote was 0.33/0.67 in the patient group and 0.00/1.00 in
the control group (P,0.001). The allele frequency of c. 163A.G was
Table 1 Sequences of oligonucleotide primers used for mutational screening of HORMAD1
Forward primer Reverse primer
Exon 2 E2F1: 59-TGTATAGGGAATAAAAATAGGA-39 E2R1: 59-AATACTTCAGCAAATATCTTCAT-39
Exon 3 E3F1: 59-CTTTTGGGGGATTACTAACC39 E3R1: 59-ACAAGTGAACTGTCAGGTACG-39
Exon 4 E4F1: 59-TGTCACCGCACTCCATCCT-39 E4R1: 59-GGGGCACAAAATAAAGAAACA-39
Exon 5 E5F1: 59-CCGAAGTTTTCCTCTCCTTG-39 E5R1: 59-ATTCAGACTGACCTACACTC-39
Exons 6, 7 E6F1: 59-TTTGTTCTTTGTTGTATTTCAGC-39 E6R1: 59-TCCTAAAACTCAAGCCCTTTCA-399
Exon 8 E8F1: 59-AGACTGAAGCCCCAAACCCAAAC E8R1: 59-CTAATCACCTAAGTTCTCTTTCCAC-39
Exon 9 E9F1: 59-GTGGAAAGAGAACTTAGGTGATT-39 E9R1: 59-ATTTGAGTGAGGTTATACTTCACA39
Exon 10 E10F1: 59-ACAGACAGTCAAGTGAAGAAA-39 E10R1: 59-CAATGTTGTTTGGGCTAAGTA-39
Exons 11, 12 E11F1: 59-CTTCCAAAGTGCTAGTAATA-39 E11R1: 59-TAAACAAATCCACCAGTAATAT-39
Exon 13 E13F1: 59-TGGTACTTTCTCAGTTCAGTGG-39 E13R1: 59-TTCTTTGTGCCTATGTAGCCTA-39
Exon 14 E14F1: 59-TTAAAAAAATTGTATATCCAGC-39 E14R1: 59-AATGAGACAGGAGATGTTTA-39
Exon 15 E15F1: 59-GAAACCCAGATATAGTTATGCT-39 E15R1: 59-AGTAAAAAGTGAATCCATACCA-39
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0.17/0.83 in the patient group and 0.00/1.00 in the control group
(P,0.001). At the c. 501T.G (SNP2, Met128Arg) site, the propor-
tion of GT heterozygote/TT homozygote was 0.13/0.87 in the
patient group and 0.00/1.00 in the control group (P,0.05). The
allele frequency of c. 501T.G (Met128Arg) was 0.07/0.93 in the
patient group and 0.00/1.00 in the control group; the difference was
significant (P,0.05) (Table 2). In the Hardy–Weinberg equilib-
rium test of the distribution of genotypes for each SNP of the
patient group, there were no SNPs showing a significant deviation
(P.0.05). Haplotype analysis revealed similar haplotype frequen-
cies estimated for all three polymorphisms in the groups (P.0.05).
Haplotype estimation and linkage disequilibrium analysis also
revealed no critical differences (P.0.05).
DISCUSSION
We predicted that mutations or polymorphisms in the HORMAD1
participate in azoospermia caused by MA. Based on these results, we
could not state that HORMAD1mutations directly caused azoosper-
mia. The number of analyzed patients is not enough to achieve a
final decision. However, we identified three cSNPs in HORMAD1.
The present association study revealed significantly different allele
frequencies at SNP1 (163A.G) and SNP2 [501T.G (Met128Arg)]
between patients with azoospermia caused by MA and fertile men.
These findings indicated that A allele at nt 163 in exon 3 and T allele
at nt 501 in exon 8 or their flanking regions may play a role in the
disruption of spermatogenesis in Japanese patients. The genotype
and allele frequency of SNP1 and SNP2 were much higher in the
azoospermia men than in the controls, indicating that HORMAD1
might play a key role in human spermatogenesis, although the num-
ber of patients analyzed was not large enough to allow a definitive
conclusion to be drawn. Regardless, the biochemical effects of the
changes at SNP1 and SNP2 are unknown. However, both SNP1 and
SNP2 were never detected in 80 normal controls. Then, the detected
SNP1 and SNP2 might be in linkage with other genes in the same
locus. There is a possibility that some genes playing the critical roles
in human spermatogenesis will be found in this region in the future.
In addition, the RNA including these two SNPs may translate a
different protein compared to the normal one. We believe that ana-
lysis of 30 men is far too small for an association study. However,
azoospermia caused by MA is very rare and our histological dia-
gnostic criteria are very strict; we have DNA samples from more
than 5000 patients with azoospermia, but only 30 of these patients
had azoospermia caused by MA.
In vitro fertilization is often an efficient way to resolve infertility
associated with female factors, but it is not as effective for severe
oligospermia in males. Although testicular sperm extraction–intracy-
toplasmic sperm injection is now performed for many patients with
azoospermia, it cannot benefit patients that lack spermatozoa in their
testes because of a complete failure in spermatogenesis. Therefore,
treatment for infertility due to non-obstructive azoospermia is an
important topic for advances in assisted reproductive technology.
In conclusion, this is the first report showing that HORMAD1 SNP
may predispose men to a defect in spermatogenesis, although the causal
and potential mechanistic relationships between these HORMAD1
SNPs and azoospermia remain unclear. Our results may provide insight
into the molecular basis of MA as a cause of non-obstructive azoosper-
mia. Additionally, whether this association exists in similar patients
from other ethnic groups must be determined in future studies.
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